블로그
- Efficacy of ATR Kinase Inhibitor Elimusertib Monotherapy or Combination in Tumors with DNA Damage... Efficacy of ATR Kinase Inhibitor Elimusertib Monotherapy or Combination in Tumors with DNA Damage Response
- Dual targeting CDK4/6 and CDK7 augments tumor response and anti-tumor immunity in breast cancer... However, their long-term efficacy is limited by acquired resistance, and CDK4/6i monotherapy remains
- A Phase II Study of Fulvestrant plus Abemaciclib in Hormone Receptor–Positive Advanced or ... –INK4–retinoblastoma pathway can overcome acquired or de novo treatment resistance to endocrine monotherapy Responses to endocrine monotherapy in advanced endometrial cancer are suboptimal, perhaps due to genomic
- [바이오스펙테이터] 릴리, 코로나19 중화항체 FDA 긴급사용 신청 그 와중에 미국의 제약회사 #일라이릴리 #EliLilly 가 #코로나 19 #중화항체 인 LY-CoV555 단일요법 (Monotherapy) 에 대해 미국 #FDA 에 긴급사용승인을